The College of American Pathologists (CAP) is seeking input from gastroenterologists as well as pathologists, oncologists and other stakeholders regarding an upcoming guideline on gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
The incidence of GEP-NETs, particularly among older adults, is increasing at a rate of 4% to 6% per year (Clin Gastroenterol Hepatol 2019;17[11]:2212-2217). The new guideline, being developed by a multidisciplinary panel, aims to provide evidence-based